Litcius/Paper detail

Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways

Q. Y. Su, Huan-Cheng Li, Xiaojing Jiang, Zhongqing Jiang, Yan Zhang, Heyi Zhang, Sheng‐Xiao Zhang

2024Biomedicine & Pharmacotherapy28 citationsDOIOpen Access PDF

Abstract

Rheumatoid arthritis (RA) is a complex autoimmune inflammatory rheumatic disease characterized by an imbalance between immunological reactivity and immune tolerance. Regulatory T cells (Tregs), which play a crucial role in controlling ongoing autoimmunity and maintaining peripheral tolerance, have shown great potential for the treatment of autoimmune inflammatory rheumatic diseases such as RA. This review aims to provide an updated summary of the latest insights into Treg-targeting techniques in RA. We focus on current therapeutic strategies for targeting Tregs based on discussing their subsets, surface markers, suppressive function, and signaling pathways in RA.

Topics & Concepts

Rheumatoid arthritisAutoimmunityImmunologyMedicinePeripheral toleranceAutoimmune diseaseImmune systemRegulatory T cellSignal transductionArthritisImmune toleranceT cellBiologyAntibodyIL-2 receptorGeneticsT-cell and B-cell ImmunologySystemic Lupus Erythematosus ResearchImmunotherapy and Immune Responses
Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways | Litcius